CME Accreditation and Designation
The China Interventional Therapeutics is accredited by the Accreditation Council for Continuing Medical Education of Ministry of Health of China to provide continuing medical education for physicians. This education activity has been designated for 8 national category-1 CME Credits in China. Three hours of physician participation in CIT equals 1 credit. Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance are provided to all registered attendees. The following activities are not included in the official CIT CME program: luncheon workshops, luncheon symposia and interventional vascular simulation sessions.

Learning Objectives
By the end of the congress, participants should be able to:
• Relate the results from important clinical trials and evidencebased medicine that guide the management of patients with atherosclerosis and structural heart disease.
• Integrate new interventional techniques and procedures to the care of patients with complex coronary artery disease, peripheral vascular disease, structural heart disease, and heart rhythm.
• Integrate appropriate pharmacological management in the care of patients undergoing diagnostic angiography and interventional therapies before, during, and after catheterization.
• Distinguish between new interventional technologies and propose their appropriate applications to patients with cardiovascular disease.

Target Audience
This congress is designed for interventional cardiologists, radiologists, clinical cardiologists, basic scientists, vascular medicine specialists, surgeons, and other health care professionals with a special interest in the field of interventional vascular therapy and medicine.

Activity Evaluation
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.

Disclosure Statement
It is the policy of the Chinese Medical Association to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity. Discussion of off-label product usage, and/or off-label product use during live cases, is made at the sole discretion of the faculty. Off-label product discussion and/or offlabel product use is not endorsed by the Chinese Medical Association or the course directors for this activity. Faculty participating in continuing medical education activities sponsored by the Chinese Medical Association are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation(s). Faculty not complying with this policy are not permitted to participate in this activity.

Program Sponsorship and Support
The congress is sponsored by Chinese Medical Association, and National Center for Cardiovascular Diseases of China, and partially funded through educational grants from commercial supporters. The CIT strives to ensure that its programs are as educational as possible and free from bias. To support this endeavor, CIT director and co-directors create organizing and scientific committees to assist in educational content development and content oversight for live cases, concurrent sessions, case reviews, workshops, and scientific symposia. These sessions are developed without influence from commercial supporters.